Orum Therapeutics Inc (475830)

Currency in KRW
89,500
-2,000(-2.19%)
Closed·
475830 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
89,10096,400
52 wk Range
15,950146,600
Key Statistics
Bid/Ask
89,400.00 / 89,500.00
Prev. Close
89,500
Open
91,400
Day's Range
89,100-96,400
52 wk Range
15,950-146,600
Volume
242.23K
Average Volume (3m)
288.33K
1-Year Change
412.605%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
475830 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Orum Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company develops BMS-986497 (ORM-6151), which is in phase 1 clinical trial to treat acuta myeloid leukemia and high-risk myelodysplastic syndromes; ORM-1153, which is in preclinical trial to treat acuta myeloid leukemia and heme-onc; and ORM-1023, which is in preclinical trial for the treatment of small cell lung cancer and neuroendocrine tumor. It also develops multiple programs; and E3 Ligase-DAC adaptor. The company was founded in 2016 and is headquartered in Daejeon, South Korea.

Compare 475830 to Peers and Sector

Metrics to compare
475830
Peers
Sector
Relationship
P/E Ratio
−45.3x−50.6x−0.5x
PEG Ratio
0.12−0.800.00
Price/Book
14.5x4.0x2.6x
Price / LTM Sales
80,643.3x20.1x3.2x
Upside (Analyst Target)
-41.0%48.8%
Fair Value Upside
Unlock−1.4%7.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
19/03/2026
EPS / Forecast
-752.83 / --
Revenue / Forecast
558.17K / --
EPS Revisions
Last 90 days

People Also Watch

180,000
476830
-3.64%
81,500
376900
-0.85%
15,070
010170
-0.13%
184,600
226950
-0.38%
194,500
141080
-4.42%

FAQ

What Is the Orum Therapeutics (KOSDAQ: 475830) Share Price Today?

The Orum Therapeutics stock price today is 89,500 KRW.

What Stock Exchange Does Orum Therapeutics (475830) Trade On?

Orum Therapeutics is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Orum Therapeutics?

The stock symbol (also called a 'ticker') for Orum Therapeutics is "475830."

What Is the Current Orum Therapeutics Market Capitalisation?

As of today, Orum Therapeutics (KOSDAQ: 475830) market cap is 1.9T KRW.

What Is Orum Therapeutics's (475830) Earnings Per Share (TTM)?

The Orum Therapeutics EPS is currently -2,017 (Trailing Twelve Months).

Is 475830 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Orum Therapeutics moving averages and other technical indicators, the daily buy/sell signal for 475830 stock is Buy.

How Many Times Has Orum Therapeutics Stock Split?

Orum Therapeutics has split 0 times. (See the 475830 stock split history page for full effective split date and price information.)

What is the current trading status of Orum Therapeutics (KOSDAQ: 475830)?

As of 29/04/2026, Orum Therapeutics (475830) is trading at a share price of 89,500 KRW, with a previous close of 89,500 KRW. The stock has fluctuated within a day range of 89,100 KRW to 96,400 KRW, while its 52-week range spans from 15,950 KRW to 146,600 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.